LORAPAED

This brand name is authorized in New Zealand, UK.

Active ingredients

The drug LORAPAED contains one active pharmaceutical ingredient (API):

1	Loratadine UNII 7AJO3BO7QN - LORATADINE
	Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.
	Read more about Loratadine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LORAPAED ALLERGY RELIEF Oral solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AX13	Loratadine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	337365
NZ	Medicines and Medical Devices Safety Authority	11512